Individualised Cost-Effectiveness Analysis in Risk-Based Screening
Personalised medicine can raise practical and ethical dilemmas. This presentation argues that there is one form of personalised medicine – risk-based screening – that can be practically and ethically implemented. It also discusses implications and applications for genomic medicine and individualised cost-effectiveness analysis more broadly.